ROCKY HILL, Conn.–(BUSINESS WIRE)–Applied Spine Technologies, Inc. www.appliedspine.com, a medical device company focused on motion preservation of the lumbar spine, received a Notice of Allowance on July 12, 2010 from the U.S. Patent and Trademark Office.
“The Company constantly manages its I.P. portfolio in order to protect and differentiate our Stabilimax platform while also working closely with its I.P. Counsel to ensure continuation of patent grants, both near term and in the years ahead.”
The application, titled ‘Dynamic spine stabilization device with travel-limiting functionality’ (U.S. application No. 11/189,512), describes the use of a travel limiting feature as part of a flexible spinal stabilization device.
“To be clinically useful, a dynamic stabilization device needs to allow the spine to move, but not move excessively,” said Bruce Robie, PhD, Vice President of Research and Development for Applied Spine. “This Notice of Allowance protects a class of devices that enable motion, like our Stabilimax device, and include structure to protect against the device moving excessively.”
“This Notice demonstrates further evidence of our ever maturing Intellectual Property,” said Craig Corrance, President and CEO of Applied Spine. “The Company constantly manages its I.P. portfolio in order to protect and differentiate our Stabilimax platform while also working closely with its I.P. Counsel to ensure continuation of patent grants, both near term and in the years ahead.”
About Applied Spine Technologies Inc., and Stabilimax®
Applied Spine Technologies Inc., headquartered in Rocky Hill, Connecticut, is developing the Stabilimax Dynamic Spine Stabilization System, a posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion. Stabilimax is expected to offer numerous advantages over current spinal fixation products and even new artificial disc products—including a much less invasive and less traumatic implant procedure, maintenance of spine motion and disc function, and the potential to prevent or slow adjacent-segment disc disease.
About the IDE Clinical Trial
Applied Spine Technologies, Inc. is currently conducting a multi-center, randomized, controlled clinical trial in the U.S. to compare posterior dynamic stabilization using the Stabilimax Dynamic Spine Stabilization System to traditional spinal fusion stabilization to treat degenerative lumbar spinal stenosis. AST has enrolled more than 100 patients to date.
Stabilimax is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.